Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Corpechot

Showing results (51-60 of 118) with videos related to

Pageof 12
Sort By:
Alimentary Pharmacology & Therapeutics|March 23, 2026
Meta-Analysis: PPAR Agonists for Pruritus and Quality of Life in Primary Biliary CholangitisAdrielly Martins, Nidah S Khakoo, Christophe Corpechot, et al.
Clinics and Research in Hepatology and Gastroenterology|August 14, 2018
Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experienceSara Lemoinne, Albert Pares, Anna Reig, et al.
Journal of Hepatology|October 22, 2008
Genetic factors of susceptibility and of severity in primary biliary cirrhosisRaoul Poupon, Chen Ping, Yves Chrétien, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2026
Hepatic and Cardiovascular Outcomes in Primary Biliary Cholangitis With Metabolic-Dysfunction Associated Steatotic Liver DiseaseJarell Jie-Rae Tan, Joo Wei Ethan Quek, Sean Shao Wei Lam, et al.
Ultrasound in Medicine & Biology|September 21, 2015
Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic AccuracyMagali Sasso, Stéphane Audière, Astrid Kemgang, et al.
JHEP Reports : Innovation in Hepatology|March 16, 2023
Protective potential of the gallbladder in primary sclerosing cholangitisNora Cazzagon, Ester Gonzalez-Sanchez, Haquima El-Mourabit, et al.
Clinics and Research in Hepatology and Gastroenterology|August 19, 2014
Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantationArmelle Poujol-Robert, Pierre-Yves Boëlle, Filomena Conti, et al.
The American Journal of Gastroenterology|July 14, 2025
PBC-HOPE: A Randomized Controlled Trial of Hypnosis and Psychoeducation in Women With Primary Biliary Cholangitis and FatigueAurélie Untas, Cécile Goffette, Cécile Flahault, et al.
Gastroenterology|February 28, 2009
Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epitheliumEmilie D'Aldebert, Marie-Jeanne Biyeyeme Bi Mve, Martine Mergey, et al.
JHEP Reports : Innovation in Hepatology|October 24, 2022
<i>A</i> <i>BCB4</i> variant is associated with hepatobiliary MR abnormalities in people with low-phospholipid-associated cholelithiasis syndromeMoustafa Biyoukar, Christophe Corpechot, Sanaâ El Mouhadi, et al.
Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
Alimentary Pharmacology & Therapeutics|March 23, 2026
Meta-Analysis: PPAR Agonists for Pruritus and Quality of Life in Primary Biliary CholangitisAdrielly Martins, Nidah S Khakoo, Christophe Corpechot, et al.
Clinics and Research in Hepatology and Gastroenterology|August 14, 2018
Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experienceSara Lemoinne, Albert Pares, Anna Reig, et al.
Journal of Hepatology|October 22, 2008
Genetic factors of susceptibility and of severity in primary biliary cirrhosisRaoul Poupon, Chen Ping, Yves Chrétien, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2026
Hepatic and Cardiovascular Outcomes in Primary Biliary Cholangitis With Metabolic-Dysfunction Associated Steatotic Liver DiseaseJarell Jie-Rae Tan, Joo Wei Ethan Quek, Sean Shao Wei Lam, et al.
Ultrasound in Medicine & Biology|September 21, 2015
Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic AccuracyMagali Sasso, Stéphane Audière, Astrid Kemgang, et al.
JHEP Reports : Innovation in Hepatology|March 16, 2023
Protective potential of the gallbladder in primary sclerosing cholangitisNora Cazzagon, Ester Gonzalez-Sanchez, Haquima El-Mourabit, et al.
Clinics and Research in Hepatology and Gastroenterology|August 19, 2014
Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantationArmelle Poujol-Robert, Pierre-Yves Boëlle, Filomena Conti, et al.
The American Journal of Gastroenterology|July 14, 2025
PBC-HOPE: A Randomized Controlled Trial of Hypnosis and Psychoeducation in Women With Primary Biliary Cholangitis and FatigueAurélie Untas, Cécile Goffette, Cécile Flahault, et al.
Gastroenterology|February 28, 2009
Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epitheliumEmilie D'Aldebert, Marie-Jeanne Biyeyeme Bi Mve, Martine Mergey, et al.
JHEP Reports : Innovation in Hepatology|October 24, 2022
<i>A</i> <i>BCB4</i> variant is associated with hepatobiliary MR abnormalities in people with low-phospholipid-associated cholelithiasis syndromeMoustafa Biyoukar, Christophe Corpechot, Sanaâ El Mouhadi, et al.
Pageof 12